Intravenous Dexamethasone for Prolonging Sensory Block in Spinal Anesthesia

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Spinal AnesthesiaPostoperative Pain ManagementDexamethasonePelvic SurgeryUrologic SurgeryProctologic Surgery
Interventions
DRUG

Dexamethasone

Single intravenous injection of 8 mg dexamethasone (2 mL) administered 5 minutes before spinal anesthesia. This intervention was tested for its effect on prolonging the duration of sensory and motor blocks induced by hyperbaric bupivacaine combined with sufentanil. The drug was administered under sterile conditions by an anesthesiologist blinded to group allocation.

DRUG

Placebo

Single intravenous injection of 2 mL isotonic saline (0.9% NaCl) administered 5 minutes before spinal anesthesia. This placebo was used to mimic the dexamethasone injection in the control group. The preparation, volume, and timing were identical to the intervention group to maintain blinding. The saline was administered under sterile conditions by an anesthesiologist blinded to group allocation.

Trial Locations (1)

1001

Habib Thameur Hospital, Tunis

All Listed Sponsors
lead

Tunis University

OTHER

NCT07088432 - Intravenous Dexamethasone for Prolonging Sensory Block in Spinal Anesthesia | Biotech Hunter | Biotech Hunter